Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
+160.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
120.4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.25M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $326000.00 | +213.5% |
| 2019 | $104000.00 | - |